India Seeks Partners With Pharmas, Hospitals To Make HIV Drugs
This article was originally published in PharmAsia News
Executive Summary
Indian health authorities are requesting public-sector drug makers to manufacture low-cost drugs against HIV. The government has plans to join with major pharmaceutical companies and hospitals to develop other vital drugs at affordable prices. Indian drug makers already have offered to cooperate with the government, but have expressed a desire for a public-private partnership to develop the drugs. The proposed link with the private sector and hospitals would expand the HIV effort to include anti-cancer and other drugs for life-threatening diseases, but which are considered too expensive since they are to be taken over a long term. (Click here for more
You may also be interested in...
India Urges Public-Private Partnerships For State-Owned Pharma Units
FRANKFURT, Germany - Indian Drugs and Pharmaceuticals Ltd., one of India's oldest government-owned units, is shedding its staid image and extending expertise and facilities to other drug companies through potential collaborations or joint ventures. Established in 1961, IDPL was formed with a socialistic outlook of fulfilling medical needs for the poor population in India
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.